Home Biotech Stocks Page 131

Biotech Stocks

Latest

Insys Therapeutics Presents Study Results Showing Rapid Absorption Of Epinephrine

ME Staff - February 26, 2019

Veritas Pharma Doses First Subject In Clinical Study Of CTL-X

OWC Pharmaceutical Cannabis Ointment Set To Proceed To PII After Positive PI Data

Reliq Health Technologies Expands Leadership Team As Investigations Continue

Zynerba Gives Clinical Update, Lifelong Impact Of ZYN002

Small Cap Biotechs with Near Term Catalysts: Minerva Neurosciences Inc (NASDAQ:NERV)...

Roger Hannington - March 15, 2016 0

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is Preparing to Release PEG-PAL Topline

- March 14, 2016 0

Vericel Corp (NASDAQ:VCEL)Draws Attention with its Phase IIb Results; Up 15%...

- March 11, 2016 1

The Week’s Biggest Movers: Aduro BioTech Inc (NASDAQ:ADRO) and Sarepta Therapeutics...

- March 11, 2016 0

Cynapsus Therapeutics Inc (NASDAQ:CYNA) set for a Game Changing Topline Release

- March 10, 2016 0

Omeros Corporation (Nasdaq:Omer) Just Kicked off a $5 Billion Pivotal Trial

ME Staff - March 9, 2016 0

Celldex Therapeutics, Inc. (NASDAQ:CLDX)’s Market Price Dives After Failure In It’s...

Andy Parker - March 8, 2016 0

Even at a 55% Discount, Celldex Therapeutics, Inc. (NASDAQ:CLDX) Still Looks...

Jennifer Aldershot - March 8, 2016 0

Movers and Shakers: Beigene Ltd (ADR) (NASDAQ:BGNE) and Proteostasis Therapeutics Inc...

Jennifer Aldershot - March 8, 2016 0

Eli Lilly and Co (NYSE:LLY) Urges Indian Government to Encourage Innovators

Carol Harper - March 7, 2016 0

1...130131132...146 Page 131 of 146

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 11-11-2024

November 10, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 10-28-2024

October 27, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 10-14-24

October 13, 2024

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.